Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Repression of Adipose Tissue Fibrosis through a PRDM16-GTF2IRD1 Complex Improves Systemic Glucose Homeostasis.

Cell metabolism | 2018

Adipose tissue fibrosis is a hallmark of malfunction that is linked to insulin resistance and type 2 diabetes; however, what regulates this process remains unclear. Here we show that the PRDM16 transcriptional complex, a dominant activator of brown/beige adipocyte development, potently represses adipose tissue fibrosis in an uncoupling protein 1 (UCP1)-independent manner. By purifying the PRDM16 complex, we identified GTF2IRD1, a member of the TFII-I family of DNA-binding proteins, as a cold-inducible transcription factor that mediates the repressive action of the PRDM16 complex on fibrosis. Adipocyte-selective expression of GTF2IRD1 represses adipose tissue fibrosis and improves systemic glucose homeostasis independent of body-weight loss, while deleting GTF2IRD1 promotes fibrosis in a cell-autonomous manner. GTF2IRD1 represses the transcription of transforming growth factor β-dependent pro-fibrosis genes by recruiting PRDM16 and EHMT1 onto their promoter/enhancer regions. These results suggest a mechanism by which repression of obesity-associated adipose tissue fibrosis through the PRDM16 complex leads to an improvement in systemic glucose homeostasis.

Pubmed ID: 29320702 RIS Download

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063720
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK108822
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK103175
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK098722
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK020541
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK026687
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK097441
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK007418
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK112304
  • Agency: NIAID NIH HHS, United States
    Id: P30 AI027763

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


European Bioinformatics Institute (tool)

RRID:SCR_004727

Non-profit academic organization for research and services in bioinformatics. Provides freely available data from life science experiments, performs basic research in computational biology, and offers user training programme, manages databases of biological data including nucleic acid, protein sequences, and macromolecular structures. Part of EMBL.

View all literature mentions

Mouse GLP/EHMT1 MAb (Clone B0422) (antibody)

RRID:AB_2097494

This monoclonal targets Mouse GLP/EHMT1 MAb (Clone B0422)

View all literature mentions

Akt (pan) (C67E7) Rabbit mAb (antibody)

RRID:AB_915783

This monoclonal targets Akt (pan) (C67E7) Rabbit mAb

View all literature mentions

Anti-UCP1 antibody (antibody)

RRID:AB_2241462

This polyclonal targets UCP1

View all literature mentions

PPARgamma (H-100) (antibody)

RRID:AB_654710

This polyclonal targets PPARG

View all literature mentions

Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb (antibody)

RRID:AB_2315049

This monoclonal targets Phospho-Akt (Ser473)

View all literature mentions

GTF2IRD1 Antibody (antibody)

RRID:AB_11006170

This unknown targets GTF2IRD1

View all literature mentions

GTF2IRD1 antibody [GTF5I102] (antibody)

RRID:AB_880320

This monoclonal targets GTF2IRD1 antibody [GTF5I102]

View all literature mentions